Clinical Trials

Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.

Cystic Fibrosis (cont’d)

Phase II
Description CF204: Paediatric Study
Sites Belgium, France, Germany, Italy, Netherlands, Switzerland, United Kingdom, Canada
Subjects 92
Status Complete
More Information


Inhaled dry powder mannitol in children with cystic fibrosis: a randomised efficacy and safety trial

Media Releases is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the website.

** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.

*** No further clinical development planned in Bronchiectasis